- Report
- April 2023
- 116 Pages
Global
From €4528EUR$4,750USD£3,860GBP
- Report
- April 2023
- 80 Pages
United States
From €4528EUR$4,750USD£3,860GBP
- Report
- August 2022
- 115 Pages
Global
From €4528EUR$4,750USD£3,860GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3098EUR$3,250USD£2,641GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3098EUR$3,250USD£2,641GBP
- Drug Pipelines
- September 2022
- 30 Pages
Global
From €3098EUR$3,250USD£2,641GBP
- Report
- February 2018
- 15 Pages
Global
- Report
- August 2022
- 115 Pages
Global
From €4528EUR$4,750USD£3,860GBP
- Report
- July 2021
- 114 Pages
Global
From €4242EUR$4,450USD£3,616GBP
- Report
- June 2022
- 16 Pages
Global
From €1859EUR$1,950USD£1,585GBP
- Report
- June 2022
- 343 Pages
Global
From €3432EUR$3,600USD£2,925GBP
- Report
- January 2022
- 233 Pages
Global
From €3432EUR$3,600USD£2,925GBP
- Report
- October 2022
- 346 Pages
Global
From €3432EUR$3,600USD£2,925GBP
- Report
- September 2022
- 118 Pages
Middle East, Africa
From €1430EUR$1,500USD£1,219GBP
- Directory
- August 2022
- 1046 Pages
Japan
From €9486EUR$9,950USD£8,085GBP
- Report
- October 2023
- 80 Pages
Global
From €3500EUR$3,933USD£3,088GBP
- Report
- May 2023
- 113 Pages
Global
From €3500EUR$3,933USD£3,088GBP
- Report
- December 2022
- 2271 Pages
Global
From €2383EUR$2,500USD£2,031GBP
- Report
- October 2022
- 94 Pages
Global
From €1907EUR$2,000USD£1,625GBP
- Report
- October 2022
- 532 Pages
Global
From €2383EUR$2,500USD£2,031GBP
Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases.
Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs.
The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs.
Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more